On Friday, the shares ended at Rs 80.25 on the BSE, valuing the company at Rs 1,993 crore.

The S&P BSE Sensex slumped 537 points, or 2.05 per cent, to 25,623.35 tracking the widespread selling in other Asian and European markets.

The S&P BSE Sensex plunged over 500 points on Monday, tracking Asian markets which slumped after China factory activity contracted.

The Indian market is expected to trade in a range. Here is a list of top twelve stocks that are likely to be in focus today.

Novartis India has completed the transaction to sell its animal health business to Elanco India, an affiliate of Eli Lilly.

In April, Novartis had agreed to divest its global Animal Health business to Lilly by transferring it to Elanco India or another affiliate ...

The S&P BSE Sensex rallied over 500 points on Friday, after the US Federal Reserve held off raising interest rates.

Indian markets are expected to trade higher. Here is a list of fifteen stocks which are likely to remain in focus today.

Elanco India is now awaiting approval from the Competition Commission of India after which both the companies will close the transaction, i...

FIPB today cleared 16 foreign direct investment proposals amounting to Rs 1,152.53 crore, including that of Edelweiss Tokio Life Insurance,...

Pharmaceuticals firm Novartis India today reported over two-fold increase in standalone net at Rs 51.94 crore for the fourth quarter ended ...

Net sales, however, rose to Rs 227.83 crore for the second quarter, as against Rs 209.18 crore for the same period of previous fiscal